Scion Asset Management BMY trades
Michael Burry
Michael Burry Bristol-Myers Squibb Company stake
total: 173
Trades details
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q4
- Held for:
- 2 quarters
- Latest activity:
- 2022 Q2
According to 2025 Q3 report, Michael Burry doesn't hold any Bristol-Myers Squibb Company (BMY) shares. To date, the estimated cost basis is nearly $62.35 for "buy" trades and estimated average "sell" price is $73.03. Scion Asset Management first purchased BMY in 2021 Q4, initially acquiring 300,000 shares. Since the initial investment in Bristol-Myers Squibb Company (BMY), Scion Asset Management has made 1 more transaction.
When did Michael Burry sell Bristol-Myers Squibb Company (BMY)?
Michael Burry sold off the entire Bristol-Myers Squibb Company (BMY) position in 2022 Q2.
When did Michael Burry buy Bristol-Myers Squibb Company (BMY)?
Michael Burry first invested in Bristol-Myers Squibb Company (BMY) in 2021 Q4 at the reported quarter-end price of $62.35 per share.
What's the cost basis of Scion Asset Management's BMY stake?
The estimated cost basis for Bristol-Myers Squibb Company (BMY) stake is around $62.35 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $62.35
- Weighted AVG sell price:
- $73.03
Michael Burry's historical trades in Bristol-Myers Squibb Company
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q2
|
0.00%
|
0
|
$73.03
|
|
-100% (-300,000)
|
-13.25%
|
|
2021 Q4
|
25.12%
|
300,000
|
$62.35
|
$18,705,000
|
new
|
+25.12%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.